Alchemab Launches First-in-Human Trial of ATLX-1282, Secures 32 Million USD Financing Boost
Alchemab Therapeutics, a biopharmaceutical company that develops naturally occurring therapeutic antibodies from resilient individuals, has announced the initiation of its first-in-human phase 1 study of ATLX-1282.
Pharma Funding | 10/09/2025 | By Darshana
US govt to provide $52.9 M to Virginia to boost pharma manufacturing
The money will be utilised to expand the domestic supply chain for essential medicines and active pharmaceutical ingredients
Pharma Funding | 12/09/2022 | By Sudeep Soparkar | 617
Govt grants in-principle approval to set up bulk drug park in Una, HP
The scheme for the promotion of bulk drug park is expected to result in incremental production of bulk drugs worth about Rs 46,400 crore
Pharma Funding | 01/09/2022 | By Sudeep Soparkar | 813
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy